Daridorexant, Idorsia's dual orexin receptor antagonist, shows consistent efficacy across both insomnia- and nocturia-related endpoints in a placebo-controlled study in patients with chronic insomnia ...
Idorsia Ltd (SIX: IDIA) today announced the publication of “A randomized cross-over trial of daridorexant for the treatment of chronic insomnia and nocturia” in the Journal of Sleep Research. The new ...
Tokyo hopes joint memorial will underline commitment to security alliance, but Hegseth expected to ask Japan to do more to ...
Good Housekeeping on MSN14h
Can a "Sleep-Focused" Hotel Guarantee the Perfect Night's Rest? I Put One to the Test.S tanding on the buckled brick sidewalk on one of Portland, Maine's busiest streets, I know I'm at my destination, but I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback